Premium
Lung Function Testing On and Off Dopaminergic Medication in Parkinson's Disease Patients With and Without Dysphagia
Author(s) -
Sawan Tareq,
Harris Mary Louise,
Kobylecki Christopher,
Baijens Laura,
Hooren Michel,
Michou Emilia
Publication year - 2015
Publication title -
movement disorders clinical practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.754
H-Index - 18
ISSN - 2330-1619
DOI - 10.1002/mdc3.12251
Subject(s) - dysphagia , parkinson's disease , medicine , lung function , dopaminergic , disease , lung , surgery , dopamine
Abstract Background Swallowing function in individuals with Parkinson's disease (PD) can be negatively affected by dopaminergic medication with associated inhibition of brainstem reflexes. Three different “swallowing‐safety” profiles of PD patients were previously observed, classified according to swallowing safety on and off levodopa. Methods Here, we investigated the effects of l ‐dopa on pulmonary function tests (PFTs) on 26 individuals with PD from the three different swallowing‐safety profiles. PFTs results were compared to predicted values and direct comparisons between the groups with or without dysphagia were performed with nonparametric statistical tests (i.e., Kruskal–Wallis). Results A short (12‐hour) withdrawal from l ‐dopa did not result in any significant changes in PFTs, and no differences on PFTs results were observed between the different dysphagic groups the on and off l ‐dopa state. No correlation was observed between the PFTs results with swallowing safety profiles of PD patients. Conclusions Although deglutition seems to be at least partially affected by dopaminergic repletion, dopaminergic mechanisms do not seem to be responsible for PD patients' performance in PFTs.